SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
27 hedge funds and large institutions have $375M invested in Sinovac Biotech, Ltd in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
Holders
27
Holders Change
+24
Holders Change %
+800%
% of All Funds
0.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
25
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VC
1
Vivo Capital
Palo Alto,
California
|
$38.2M |
| 2 |
2
Renaissance Technologies
New York
|
$849K |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$109K |
| 4 |
4
Morgan Stanley
New York
|
$54K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$14.3K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
| $0 | 40,000 | +40,000 | New |
|
27
California Public Employees Retirement System
Sacramento,
California
| $0 | 68,732 | +68,732 | New |
|